MedTrace Logo

Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication

NCT02175901 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 215

Last updated 2015-02-03

No results posted yet for this study

Summary

No trial has examined the the efficacy of amoxicillin and metronidazole based quadruple therapy for Helicobacter pylori treatment. The study aims to compare the effectiveness and safety of 14-day amoxicillin-/metronidazole-based quadruple regiment and classical quadruple regiment for Helicobacter pylori eradication.

Conditions

  • Dyspepsia
  • Peptic Ulcer

Interventions

DRUG

Lansoprazole

antisecretory drug of each quadruple therapy

DRUG

Bismuth Potassium Citrate

one component of each quadruple therapy

DRUG

Amoxicillin

antibiotic of each quadruple therapy

DRUG

Metronidazole

antibiotic of the amoxicillin/metronidazole-based quadruple therapy

DRUG

Clarithromycin

antibiotic of the amoxicillin/clarithromycin-based quadruple therapy

Sponsors & Collaborators

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Hong Lu, M.D. · RenJi Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02175901 on ClinicalTrials.gov